Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 30 out of 100. Health systems and care delivery

Topic: Risk, prevention and care in population studies

Europe's ageing population is transforming universal healthcare from a financing challenge into a delivery-capacity challenge. Longer lives are increasingly accompanied by multimorbidity, polypharmacy, dementia, cardiometabolic disease, cancer, mobility loss and functional limitation, with rural regions facing the most rapidly ageing population and the weakest service infrastructure. Therapeutic innovations, including incretin-based metabolic therapies, immuno-oncology, antibody-drug conjugates and earlier detection technologies, may extend healthy ageing but will also increase demand for coordinated outpatient care, safe medication regimens, reimbursement discipline and interoperable data. This perspective outlines a 24-36-month European Union agenda: professionalize the long-term care workforce, embed pharmacist-led medication review, expand home and step-down care, and make shared discharge summaries, medication lists and care plans routine across settings.

Key findings

Why it matters

This perspective describes how Europe's ageing population is straining healthcare delivery, with dementia among the conditions accompanying longer lives, and proposes a 24-36 month EU agenda including workforce and care coordination measures. It is a policy commentary and does not report any treatment, cure or prevention of Alzheimer's disease.

Study details

How this study scored 30/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 3 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 1 of 4; Institution's track record left out, no data; Multi-centre collaboration 0 of 3; Indexed in PubMed 2 of 2; Free to read 0 of 2. 29 of the 97 points it could be judged on, which is 30 of 100. Total 30 of 100.29 of the 97 points we could judge = 30 of 100

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it. We have no data on institution's track record, so that was left out: it earned 29 of the 97 points we could judge it on, which is 30 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Drug discovery today)
Journal's citation record 3 / 4 Drug Discovery Today: journal h-index 250 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 2 year(s) since 2026
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 1 / 4 Last-listed author Mikael Dolsten: h-index 10 (OpenAlex, whole career)
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multi-centre collaboration 0 / 3 OpenAlex lists 0 institution(s) in 0 countries — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 42476293)
Free to read 0 / 2 Behind a paywall — scores zero
Points 29 / 97 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 29 of the 97 points we could judge it on is 30 out of 100.
Total 30 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Jones Charles, H., Marie, B., & Mikael, D. (2026). Universal care under strain: navigating population ageing in Europe. Drug discovery today. https://doi.org/10.1016/j.drudis.2026.104743

Vancouver

Jones Charles H, Marie B, Mikael D. Universal care under strain: navigating population ageing in Europe. Drug discovery today. 2026. doi:10.1016/j.drudis.2026.104743. PMID: 42476293.

BibTeX

@article{jonescharles2026-42476293,
  author  = {Jones Charles, H. and Marie, Beitelshees and Mikael, Dolsten},
  title   = {{Universal care under strain: navigating population ageing in Europe}},
  journal = {Drug discovery today},
  year    = {2026},
  doi     = {10.1016/j.drudis.2026.104743},
  pmid    = {42476293},
  url     = {https://doi.org/10.1016/j.drudis.2026.104743}
}

Related studies in Health systems and care delivery

Similar studies

More on Health systems and care delivery

See all studies in Health systems and care delivery →